Preliminary evaluation of the candidate international reference for Epstein–Barr virus capsid antigen immunoglobulin A in China

Hao Chen,Qiaohua Zhong,Xiaobin Wu,Yanling Ding,Qi Chen,Ning Xue,Shulin chen,Yi-Wei Xu
DOI: https://doi.org/10.21203/rs.2.23134/v1
2020-02-11
Abstract:Abstract Background: Epstein–Barr capsid antigen (VCA) immunoglobulin A (IgA) detection is widely used for nasopharyngeal carcinoma (NPC), but reference standard for VCA-IgA has not yet been determined. For uniform and quantitative detection of VCA- IgA, reference standard is in urgent need. Methods: A mixed reference serum from three patients with NPC diluted with healthy subjects serum was made as a possible first international standard for VCA-IgA. Four ELISA kits and two chemiluminescent immunoassays(CLIA) kits were used to detected VCA-IgA in twenty NPC patients using the reference as a calibration curve. The performance of six kits were evaluated, and the quantitative results were compared. Results: Our results shown the reference has good linearity in different kits. Without reference, the difference of total CV (from 3.98% to 43.11%) and Within-run CV(from 2.47% to 19.66%) was large in 6 kits. The positive and negative coincidence rate between 6 kits and IFA for NPC diagnosis was 75% overall agreement, but there was a difference among the six kits ranged from 55%-90%. Concentration of 20 NPC samples divided into three sample categories was shown significant difference in a few subgroup of 6 methods. But a good correlation (R2=986) was observed between Antu and Beier ELISA kits. Conclusions: The reference serum may be used as a reference standard and better compared results from different methods/laboratories. However, due to the diversity of VCA antigens, the quantitative results of some kits are still inconsistent.
What problem does this paper attempt to address?